SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report.


Journal

Diagnostic cytopathology
ISSN: 1097-0339
Titre abrégé: Diagn Cytopathol
Pays: United States
ID NLM: 8506895

Informations de publication

Date de publication:
Oct 2023
Historique:
revised: 03 07 2023
received: 17 04 2023
accepted: 12 07 2023
medline: 4 9 2023
pubmed: 21 7 2023
entrez: 21 7 2023
Statut: ppublish

Résumé

SMARCB1 (INI1) is one of the switch/sucrose nonfermentable (SWI/SNF) complexes whose loss is associated with several tumors. SMARCB1 (INI1)-deficient intrathoracic neoplasms are extremely rare and known to be highly malignant and lethal. This report presents the case of a patient diagnosed with SMARCB1 (INI1)-deficient intrathoracic neoplasm during chemotherapy for plasma cell myeloma. A 77-year-old male patient complained of cough, bloody sputum, and fever with an enlarged right lung mass and pleural effusion. His cytological examination revealed undifferentiated epithelioid and rhabdoid/plasmacytoid cells with bi- or multinucleation, vacuolization, mitosis, and pleomorphism. However, it was difficult to distinguish the relapse of plasma cell myeloma as atypical plasmacytoid cells were detected. Immunohistochemically, the neoplastic cells showed a loss of SMARCB1 (INI1) expression in the cell block of pleural fluid and in the right lung of the autopsy specimen. Further, the patient was diagnosed with SMARCB1 (INI1)-deficient intrathoracic neoplasm of the right lung based on histological and autopsy findings. To the best of our knowledge, this is the first report of cytomorphology in a SMARCB1 (INI1)-deficient intrathoracic neoplasm.

Identifiants

pubmed: 37475580
doi: 10.1002/dc.25197
doi:

Substances chimiques

SMARCB1 Protein 0
Biomarkers, Tumor 0
SMARCB1 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E294-E300

Informations de copyright

© 2023 The Authors. Diagnostic Cytopathology published by Wiley Periodicals LLC.

Références

Chabanon RM, Morel D, Postel-Vinay S. Exploiting epigenetic vulnerabilities in solid tumors: novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers. Semin Cancer Biol. 2020;61:180-198.
WHO classification of tumors editorial board. WHO classification of tumors. Thoracic Tumors. Vol 5. 5th ed. World Health Organization; 2021:111-114.
Kohashi K, Oda Y. Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Cancer Sci. 2017;108:547-552.
Alessi JV, Ricciuti B, Spurr LF, et al. SMARCA4 and other SWItch/sucrose nonfermentable family genomic alterations in NSCLC: Clinicopathologic characteristics and outcomes to immune checkpoint inhibition. J Thorac Oncol. 2021;16:1176-1187.
Haberecker M, Bühler MM, Mendieta AP, et al. Molecular and immunophenotypic characterization of SMARCB1 (INI1): deficient intrathoracic neoplasms. Mod Pathol. 2022;35:1860-1869.
Rickard JA, Burr ML, Williams B, et al. SMARCB1/INI1-deficient primary lung carcinoma with hepatic metastasis. Pathology. 2022;54:817-820.
Yoshida K, Fujiwara Y, Goto Y, et al. The first case of SMARCB1 (INI1): deficient squamous cell carcinoma of the pleura: a case report. BMC Cancer. 2018;18:398.
Priya D, Sadasivan B, Patil Okaly GV, Mukunda Pai M, Alashetty S, Kavitha BL. Cytomorphological and immunohistochemical features of renal and extrarenal rhabdoid tumors. Diagn Cytopathol. 2021;49:711-717.
Sharma R, Thirunavukkarasu B, Nalwa A, Pathak M, Garg PK. Malignant rhabdoid tumour of liver: conundrum on ascitic fluid. Diagn Cytopathol. 2023;51:276-279.
Tomomasa R, Nakata S, Nobusawa S, et al. Primary diffuse leptomeningeal atypical teratoid/rhabdoid tumor diagnosed by cerebrospinal fluid cytology: case report with molecular genetic analysis. Hum Pathol. 2018;77:116-120.
Wakely PE Jr. Cytopathology of classic type epithelioid sarcoma: a series of 20 cases and review of the literature. J Am Soc Cytopathol. 2020;9:126-136.
Wang L, Yee-Chang M, Sun W, Melamed J, Simsir A, Shi Y. Myoepithelial carcinoma of soft tissue is a diagnostic challenge on fine-needle aspiration: case report and review of literature. Diagn Cytopathol. 2022;50:E203-E209.
Allison DB, Bishop JA, Ali SZ. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasalcarcinoma: a potential diagnostic pitfall. Diagn Cytopathol. 2016;44:700-703.
Minoshima A, Sugita S, Segawa K, et al. Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4-deficient undifferentiated tumor: a case report. Diagn Cytopathol. 2023;51:E149-E154.
WHO classification of tumors editorial board. WHO classification of tumors. Haematopoietic and Lymphoid Tumors. 4th ed. World Health Organization; 2017:243.
Gochhait D, Dey P, Verma N. Cytology of plasma cell rich effusion in cases of plasma cell neoplasm. J Cytol. 2016;33:150-153.

Auteurs

Kazuki Fujita (K)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Keishi Mizuguchi (K)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Tatsuya Mori (T)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Tsubasa Shimoda (T)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Kaori Sakano (K)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Chie Shimaguchi (C)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Ayumi Ito (A)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Kaori Yoshimura (K)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Maki Sakaguchi (M)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Tatsuya Imi (T)

Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.

Hiroko Ikeda (H)

Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH